Phase II trial of razoxane in the management of recurrent adenocarcinoma of the ovary: a Gynecologic Oncology Group study.

• Authors: J F Conroy, J A Blessing, A Kessinger, H D Homesley
• Journal: Cancer treatment reports (Cancer Treat Rep) Vol. 68 Issue 2 Pg. 439-40 (Feb 1984) ISSN: 0361-5960 [Print] United States
• PMID: 6697335 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)

Chemical References

• Piperazines
• Razoxane

Topics

• Adenocarcinoma (drug therapy)
• Adult
• Aged
• Drug Evaluation
• Female
• Humans
• Leukopenia (chemically induced)
• Middle Aged
• Nausea (chemically induced)
• Neoplasm Recurrence, Local (drug therapy)
• Ovarian Neoplasms (drug therapy)
• Piperazines (therapeutic use)
• Razoxane (adverse effects, therapeutic use)
• Thrombocytopenia (chemically induced)